
Hikal Earns EcoVadis Gold Medal, Securing a Top 5% Ranking Globally for Sustainability Performance
Hikal Limited, a major supplier to global pharmaceutical and crop protection companies, has received the prestigious EcoVadis Gold Medal rating. This recognition places the company among the top 5% of more than 175,000 businesses evaluated annually by EcoVadis globally.The EcoVadis assessment, which is the world's largest provider of business sustainability ratings and covers over 185 countries and 250+ industries, saw Hikal achieve an overall score of 84/100, securing a 97th percentile ranking. The company noted that it is one point short of achieving the Platinum Medal threshold of 85/100 and aims to meet this milestone in the subsequent assessment cycle.
The Gold Medal reflects Hikal's dedication to sustainable business practices across four key areas evaluated by EcoVadis: Environment, Labour & Human Rights, Ethics, and Sustainable Procurement.
Commenting on the achievement, Sameer Hiremath, Vice Chairman and Managing Director of Hikal, stated that the recognition highlights the company's commitment to integrating sustainability into its operations and strategic culture. Mr. Hiremath added that the Gold Medal reflects progress made in environmental stewardship, ethical business practices, responsible manufacturing, and sustainable procurement, reinforcing their resolve for long-term value creation through responsible growth.
The certification carries significant weight within global supply chains, particularly in the life sciences and specialty chemicals sectors. Customers increasingly expect suppliers to demonstrate measurable commitments regarding sustainability, ethics, labor standards, and responsible sourcing. The Gold Medal underscores Hikal's Environmental, Social, and Governance performance, boosting its credibility with both investors and international clients who often use EcoVadis ratings as a critical criterion for supplier partnerships.
Established in 1988, Hikal serves as a reliable partner to industries spanning Pharmaceutical, Animal Health, Crop Protection, and Specialty Chemicals. The company manufactures and supplies Active Ingredients, Intermediates, and Biocides to the global life sciences industry. Hikal operates five manufacturing facilities in India—located in Taloja and Mahad (Maharashtra), Panoli (Gujarat), and Jigani (Bengaluru)—alongside a Research & Technology center in Pune. The company is one of the first Indian life-sciences companies to receive the Responsible Care® certification, maintaining a focus on inclusive growth and employee health through best manufacturing practices.
HIKAL Stock Price Movement
Today, shares of Hikal Limited rallied to close at ₹221.38, gaining 2.26% during the trading session. The stock traded within an intraday range of ₹216.99 and a high of ₹224, logging a volume of 243,580 shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.